National Support Campaigns

Changes/additions to materials:

The NHS Institute for Innovation and Improvement has recently released four Better Care, Better Value Indicators (BCBV) relating to prescribing. Two BCBV indicators relating to statins and lipid modification are listed:

• Increasing low cost statin prescribing, which is defined as “the number of prescription items for low cost statins (simvastatin and pravastatin). This is expressed as a percentage of the total number of prescriptions for all statins (excluding combination products).”

• Increasing low cost prescribing for lipid modification, which is defined as “the number of prescription items for low cost statins (simvastatin and pravastatin). This is expressed as a percentage of the total number of prescriptions for all statins including combinations of ezetimibe▼ with statins.”

A guide to the support materials for this topic is available in the library.

Statins Data Focussed Commentary

We have produced data-focussed commentaries to highlight areas where there appear to be differences between the evidence-base, as described elsewhere on this floor, and current clinical practice. These resources can be read on the screen by clicking the 'flash' version, or by downloading and printing the 'PDF' version.

This commentary covers high cost and low cost statin usage, rosuvastatin and ezetimibe.